Mascarenhas J, Virtgaym E, Stal M, et al. Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: a sponsor-independent international study. Ann Hematol. 2018, 97(8):1369-1374. doi: 10.1007/s00277-018-3309-6.
Advertisement
Articles by Mascarenhas J, Virtgaym E, Stal M, et al. Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: a sponsor-independent international study. Ann Hematol. 2018, 97(8):1369-1374. doi: 10.1007/s00277-018-3309-6.
Advertisement
Latest Updated Articles
- Study Summary: Compassionate Use of Pacritinib in Patients With Myelofibrosis
Published: August 28th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Respiratory Vaccination by the Numbers: COVID-19, Flu, and RSV
2
NYC Nurses Strike Enters Day 5 Amid Staffing, Safety, and Benefit Disputes
3
Lipid Management Remains Central to Cardiovascular Risk Reduction in CKD
4
Inside the 24-Hour Reversal of SAMHSA Grant Cuts With NAMI's Jennifer Snow, MPA
5
